Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taroh Satoh

Showing results (61-70 of 277) with videos related to

Pageof 28
Sort By:
Oncotarget|September 20, 2019
Application of <i>C. elegans</i> cancer screening test for the detection of pancreatic tumor in genetically engineered miceYuji Ueda, Koichi Kawamoto, Masamitsu Konno, et al.
Cancer Chemotherapy and Pharmacology|December 1, 2006
Phase I study of TZT-1027, a novel synthetic dolastatin 10 derivative and inhibitor of tubulin polymerization, which was administered to patients with advanced solid tumors on days 1 and 8 in 3-week coursesKenji Tamura, Kazuhiko Nakagawa, Takayasu Kurata, et al.
Japanese Journal of Clinical Oncology|September 12, 2014
Incidence and clinical features of drug-induced lung injury in patients with advanced colorectal cancer receiving cetuximab: results of a prospective multicenter registryTaroh Satoh, Akihiko Gemma, Shoji Kudoh, et al.
Scientific Reports|April 6, 2023
The potential clinical utility of cell-free DNA for gastric cancer patients treated with nivolumab monotherapyChiaki Inagaki, Hisato Kawakami, Daichi Maeda, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|December 4, 2025
Efficacy and safety of irinotecan-based therapy in elderly patients with advanced gastric cancer receiving third-line or later chemotherapy: post-hoc age-subgroup analysis of the rindberg trialRyohei Kawabata, Daisuke Sakai, Toshio Shimokawa, et al.
Oncology Letters|July 3, 2015
Surgically resected human tumors reveal the biological significance of the gastric cancer stem cell markers CD44 and CD26Shimpei Nishikawa, Masamitsu Konno, Atsushi Hamabe, et al.
Biomedical Reports|May 8, 2018
Fetal hepatocyte-derived culture medium elicits adipocyte differentiation to bile duct cell lineages in a mouse modelHisataka Ogawa, Masamitsu Konno, Koichi Kawamoto, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 17, 2023
[A Case of Squamous Cell Carcinoma of the Lower Rectum]Mao Osaki, Tsuyoshi Hata, Yuki Sekido, et al.
Esophagus : Official Journal of the Japan Esophageal Society|April 28, 2026
First-line pembrolizumab plus chemotherapy versus chemotherapy alone for advanced esophageal cancer: 5-year extended follow-up in the Japanese subgroup of KEYNOTE-590Ken Kato, Takashi Kojima, Hiroki Hara, et al.
Scientific Reports|January 12, 2018
Enzymes of the one-carbon folate metabolism as anticancer targets predicted by survival rate analysisJun Koseki, Masamitsu Konno, Ayumu Asai, et al.
Pageof 28

Showing results (61-70 of 277) with videos related to

Sort By:
Pageof 28
Oncotarget|September 20, 2019
Application of <i>C. elegans</i> cancer screening test for the detection of pancreatic tumor in genetically engineered miceYuji Ueda, Koichi Kawamoto, Masamitsu Konno, et al.
Cancer Chemotherapy and Pharmacology|December 1, 2006
Phase I study of TZT-1027, a novel synthetic dolastatin 10 derivative and inhibitor of tubulin polymerization, which was administered to patients with advanced solid tumors on days 1 and 8 in 3-week coursesKenji Tamura, Kazuhiko Nakagawa, Takayasu Kurata, et al.
Japanese Journal of Clinical Oncology|September 12, 2014
Incidence and clinical features of drug-induced lung injury in patients with advanced colorectal cancer receiving cetuximab: results of a prospective multicenter registryTaroh Satoh, Akihiko Gemma, Shoji Kudoh, et al.
Scientific Reports|April 6, 2023
The potential clinical utility of cell-free DNA for gastric cancer patients treated with nivolumab monotherapyChiaki Inagaki, Hisato Kawakami, Daichi Maeda, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|December 4, 2025
Efficacy and safety of irinotecan-based therapy in elderly patients with advanced gastric cancer receiving third-line or later chemotherapy: post-hoc age-subgroup analysis of the rindberg trialRyohei Kawabata, Daisuke Sakai, Toshio Shimokawa, et al.
Oncology Letters|July 3, 2015
Surgically resected human tumors reveal the biological significance of the gastric cancer stem cell markers CD44 and CD26Shimpei Nishikawa, Masamitsu Konno, Atsushi Hamabe, et al.
Biomedical Reports|May 8, 2018
Fetal hepatocyte-derived culture medium elicits adipocyte differentiation to bile duct cell lineages in a mouse modelHisataka Ogawa, Masamitsu Konno, Koichi Kawamoto, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 17, 2023
[A Case of Squamous Cell Carcinoma of the Lower Rectum]Mao Osaki, Tsuyoshi Hata, Yuki Sekido, et al.
Esophagus : Official Journal of the Japan Esophageal Society|April 28, 2026
First-line pembrolizumab plus chemotherapy versus chemotherapy alone for advanced esophageal cancer: 5-year extended follow-up in the Japanese subgroup of KEYNOTE-590Ken Kato, Takashi Kojima, Hiroki Hara, et al.
Scientific Reports|January 12, 2018
Enzymes of the one-carbon folate metabolism as anticancer targets predicted by survival rate analysisJun Koseki, Masamitsu Konno, Ayumu Asai, et al.
Pageof 28